Published on: 2026-03-11
UAMY, the ticker for United States Antimony, surged in the latest U.S. session. UAMY stock closed at $11.23 on March 10, 2026, up 16.98% for the day, after trading as high as $11.30 with volume above 21 million shares.
The move did not come out of nowhere. It followed two company-specific catalysts released within days of each other: a $27 million award tied to domestic antimony supply chain expansion, and approval to uplist from NYSE American to the New York Stock Exchange, with trading expected to begin on March 11, 2026.
This article breaks down every key driver behind the surge, evaluates whether the move is fundamentally justified, and identifies the critical technical price levels every investor should monitor over the next 48 hours.
Hard catalyst: $27 million Defense Production Act Title III award.
Hard catalyst: Approved uplisting to the NYSE, effective around March 11, 2026.
Soft catalyst: Heavy trading volume, nearly 1.9 times the recent 20-day average.
Soft catalyst: Short interest near 22.8% of float, which can amplify squeezes.
Soft catalyst: A rapid sequence of press releases, conference appearances, and media exposure has kept sentiment hot
The main drivers of UAMY's latest surge are straightforward. First, the company announced a $27 million government award to expand domestic antimony extraction, processing, and refinement.
Second, it announced that its shares have been approved to uplist from the NYSE American to the New York Stock Exchange, a move management believes will improve trading characteristics and broaden the investor base. Those are real catalysts, not rumor-driven headlines.
The size of the move, though, is not just about fundamentals. UAMY also has high short interest, strong volume, and a steady stream of company announcements that have kept the stock in front of momentum traders. That mix often leads to outsized price swings in both directions.
On March 5, 2026, UAMY announced it had been awarded $27 million by the Department of War under Title III of the Defense Production Act (DPA) to enhance, innovate, and expand domestic extraction, processing, and refinement of antimony.
This is one of three DPA investments totaling $58.5 million made since the start of fiscal year 2026. The specific use of funds includes:
Modernization and capacity expansion of the Thompson Falls, Montana, smelter
Acceleration of Montana production to approximately 400 to 500 tons of finished antimony product per month by early April 2026
Support for vertical mining integration in both Alaska and Montana
A company cost-share contribution of $3.9 million, representing approximately 14.4% of the total award
The timing of this award aligns directly with Executive Order 14241, signed on March 20, 2025, which directed immediate measures to increase American mineral production. This government endorsement signals that UAMY is not only operationally capable but is considered a critical partner in national supply chain resilience.
The second catalyst is the exchange upgrade. UAMY said it had been approved to uplist from NYSE American to the NYSE, with trading expected to begin on March 11 under the same ticker symbol. The company stated that the move should enhance trading characteristics and help broaden its institutional and retail shareholder base.
An uplisting itself does not affect revenue or profit, but it can alter a stock's market perception. For smaller companies, a main-board NYSE listing can help attract funds and traders that prefer higher-profile exchanges. That helps explain why the stock reacted so quickly to the announcement.
UAMY has not relied on a single press release. In the span of days, the company also highlighted a technical report on its Fostung tungsten deposit, a capital markets conference appearance, and additional media visibility.
Earlier this year, it also announced a joint venture to build a hydromet processing facility and a property acquisition tied to critical minerals processing.
That matters because small-cap rallies often need a continuing story to stay alive. UAMY has had one. Traders are not just reacting to one headline. They are reacting to a chain of headlines that reinforces the same growth narrative.
The stock's trading mechanics are also helping push it around. StockAnalysis reports that approximately 27.7 million shares have been sold short, representing 22.78% of the float.
The average trading volume over the past 20 days was approximately 11.3 million shares, while intraday trading on March 11 exceeded 21 million shares. This setup has the potential to amplify positive news into a much more significant market move.
That does not guarantee a short squeeze, but it does mean price action can overshoot on both the way up and the way down. Traders should respect that risk.
This is where the story gets more balanced. UAMY's business has improved. The company reported revenue of $14.94 million in 2024, an increase of nearly 72% from $8.69 million in 2023.
At the same time, the net loss decreased to approximately $1.74 million, down from around $6.36 million the previous year. In the past twelve months, the company's revenue reached $31.86 million; however, it continues to experience a loss of approximately $4.94 million.
So yes, there is a real growth story. But the market is already pricing in a lot more than the current numbers show.
| Metric | Current | Historical Context |
|---|---|---|
| Market cap | $1.57B | $26.8M at year-end 2023; $200M at year-end 2024 |
| Price to sales | 47.34x | About 7.1x average from 2020 to 2024, by calculation |
| Price to book | 17.42x | About 3.4x average from 2020 to 2024, by calculation |
| TTM revenue | $31.86M | 2024 revenue was $14.94M |
| Net income | -$4.94M TTM | 2024 net loss was $1.74M |
| Cash | $19.61M | Useful cushion, but small relative to current valuation |
The table above indicates that the rally is only partially supported by fundamentals. While the strong catalysts are genuine and enhance the company's long-term strategic position, the current valuation is significantly ahead of revenue, book value, and profitability.
In simpler terms, the market is valuing the company based on expected future growth rather than its current financial performance.
From a technical perspective, UAMY is still in a bullish structure on the daily chart. The stock is well above its 50-day moving average of $8.28 and its 200-day moving average of $6.16. Its RSI is about 64.7, which is strong but not yet at an extreme reading.
| Level | Type | Why It Matters |
|---|---|---|
| $10.65 to $10.72 | Immediate support | March 2 breakout area and recent pivot zone |
| $9.38 to $9.60 | Stronger support | March 11 intraday low and recent closing support area |
| $8.80 to $9.00 | Deeper support | March 5 to March 6 lows, where buyers last stepped in |
| $11.28 to $11.30 | Near-term resistance | March 11 intraday high |
| $11.95 to $12.00 | Major resistance | January 26 swing high near $11.97 and round-number pressure |
For bulls, the clean signal is a hold above the $10.65 to $10.72 zone, followed by another push through $11.30. If that happens, traders will likely test the $12.00 area quickly.
For bears, the first real win would be a break back under $10.65. A failure there would raise the odds of a deeper flush toward the mid-$9 area.
UAMY is up because the market is reacting to a $27 million government award tied to antimony expansion and a move to the New York Stock Exchange. Strong volume and high short interest appear to be magnifying the reaction.
Yes, it is one of the main drivers. The company announced that trading on the NYSE will begin on March 11, 2026. This move is expected to enhance its trading profile and broaden shareholder reach.
At this stage, yes, partly. The company has real business catalysts, but the speed of the move suggests momentum traders, retail flows, and short-covering are also active.
That depends on follow-through. Traders will want to see the stock hold above recent breakout levels and stay supported by news flow.
Yes. UAMY stock has shown significant daily fluctuations, and its recent strength follows a substantial decline from its October 2025 peak.
In conclusion, UAMY stock is not moving on empty hype. The latest surge is tied to real news, especially the $27 million government award and the NYSE uplisting. Those are meaningful hard catalysts, and they help explain why buyers stepped in so aggressively.
However, the current valuation of the stock is inflated compared to its historical levels. UAMY's market cap, price-to-sales ratio, and price-to-book ratio all suggest investors are already pricing in a much larger company than the one reflected in current revenue and earnings.
That does not mean the rally has to end immediately. It does mean the next move will likely depend on execution, not just excitement.
Disclaimer: This material is for general information purposes only and is not intended as (and should not be considered to be) financial, investment or other advice on which reliance should be placed. No opinion given in the material constitutes a recommendation by EBC or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person.
